Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Neuroscience

Research Field Neuroscience

Viewing the Inaccessible

| Geoffrey Potjewyd | 2 min read

The brain and cerebral vasculature are notoriously difficult to access – is OCT the key to the door?

Disease Area Neurological

Of Mice and Men

| Geoffrey Potjewyd

Mouse vision is presumed to have low spatial resolution – but the discovery of the focea begs to differ

Research Field Neuroscience

We Need to Talk About Clinical Representation

Alzheimer’s research should benefit all, regardless of ethnicity or race

Tools & Techniques Diagnostics & prognostics

Catching Stroke Early with Blood-Based Testing

| Olivia Gaskill

Blood biomarkers specific to brain damage may help identify early signs of stroke

Disease Area Cell & gene therapy

The Genomic Revolution

| Stephanie Sutton

Can genomic medicine usher in a new era of curative treatments for neurological diseases? Experts from Sangamo give their views

Disease Area Cell & molecular biology

Protein Expression In Neurogenesis: Right Place, Right Time?

| Olivia Gaskill

Phf21b, a protein associated with intellectual disability and depression, plays a crucial role in neurogenesis.

Research Field Clinical trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

Disease Area Drug discovery

Rejuvenating Alzheimer’s R&D

| Maryam Mahdi

How can we encourage companies to pursue clinical research for CNS disorders?

Disease Area Neurological

A Brave New World of Retina Research

| Allen C. Ho, Carl D. Regillo

Cutting-edge translational retina research for patients in Philadelphia and around the world

Disease Area Neurological

Getting on Target for Alzheimer’s

| Neil Cashman, James Kupiec

"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."


Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register